Value-Based Cancer Care Issues


April 2011, Vol 2, No 2

Preparing for Future Trends in Cancer Care

ACCC Conference

Washington, DC—Oncologists must plan for and invest in future trends and expected growth using available evidence- based information, said Rebecca Booi, PhD, Director of Cancer Solutions at Sg2, during the 2011 Association of Community Cancer Centers 37th Annual National Meeting. [ Read More ]

FDA Approved First Generic Docetaxel

FDA Approvals, News & Updates

The US Food and Drug Administration (FDA) approved docetaxel injection (Hospira)—the first generic formulation of Taxotere (sanofi-aventis). Generic docetaxel is already available in Europe and Australia. Docetaxel, an antineoplastic chemotherapy medication, is indicated for the treatment of several cancers at [ Read More ]

NCCN 2011 Clinical Guidelines Updates

NCCN Conference

Hollywood, FL—Chairpersons of the various National Comprehensive Cancer Network (NCCN) tumor panels presented clinical practice updates at the recent 16th Annual Conference of the NCCN. Key updates, and relevant discussions, are highlighted. Key Changes in Breast Cancer Recommendations Pivotal research [ Read More ]